DE60305642D1 - In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil - Google Patents

In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil

Info

Publication number
DE60305642D1
DE60305642D1 DE60305642T DE60305642T DE60305642D1 DE 60305642 D1 DE60305642 D1 DE 60305642D1 DE 60305642 T DE60305642 T DE 60305642T DE 60305642 T DE60305642 T DE 60305642T DE 60305642 D1 DE60305642 D1 DE 60305642D1
Authority
DE
Germany
Prior art keywords
piribedil
pharmaceutical composition
mouth valve
dispersible pharmaceutical
dispersible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60305642T
Other languages
English (en)
Other versions
DE60305642T2 (de
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of DE60305642D1 publication Critical patent/DE60305642D1/de
Publication of DE60305642T2 publication Critical patent/DE60305642T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60305642T 2002-01-21 2003-01-21 In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil Expired - Lifetime DE60305642T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0200671A FR2834894B1 (fr) 2002-01-21 2002-01-21 Composition pharmaceutique orodispersible de piribedil
FR0200671 2002-01-21
PCT/FR2003/000179 WO2003061661A1 (fr) 2002-01-21 2003-01-21 Composition pharmaceutic orodispersible de piribedil

Publications (2)

Publication Number Publication Date
DE60305642D1 true DE60305642D1 (de) 2006-07-06
DE60305642T2 DE60305642T2 (de) 2007-05-16

Family

ID=27589523

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60305642T Expired - Lifetime DE60305642T2 (de) 2002-01-21 2003-01-21 In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil

Country Status (27)

Country Link
US (1) US20050085485A1 (de)
EP (1) EP1467737B1 (de)
JP (1) JP4500051B2 (de)
KR (1) KR100588223B1 (de)
CN (1) CN100352440C (de)
AR (1) AR038194A1 (de)
AT (1) ATE327758T1 (de)
AU (1) AU2003214326B2 (de)
BR (1) BR0306869A (de)
CA (1) CA2473152C (de)
CY (1) CY1105414T1 (de)
DE (1) DE60305642T2 (de)
DK (1) DK1467737T3 (de)
EA (1) EA007286B1 (de)
ES (1) ES2263959T3 (de)
FR (1) FR2834894B1 (de)
GE (1) GEP20063819B (de)
HK (1) HK1081110A1 (de)
MA (1) MA27098A1 (de)
MX (1) MXPA04007035A (de)
NO (1) NO20043474L (de)
NZ (1) NZ533820A (de)
PL (1) PL204939B1 (de)
PT (1) PT1467737E (de)
UA (1) UA78277C2 (de)
WO (1) WO2003061661A1 (de)
ZA (1) ZA200405008B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575343A (de) * 1955-09-09
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
JP3253127B2 (ja) * 1991-06-07 2002-02-04 帝國製薬株式会社 生理活性ポリペプチド含有製剤
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
JP3122141B2 (ja) * 1994-01-31 2001-01-09 山之内製薬株式会社 口腔内溶解型圧縮成型物及びその製造法
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
EP1007083A1 (de) * 1997-05-09 2000-06-14 Feronpatent Limited Stabilisierung von wässrigen interferon-lösungen zur herstellung von sublingualen tabletten
JP2983973B1 (ja) * 1998-10-13 1999-11-29 大正薬品工業株式会社 口腔内速崩壊性固形製剤
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
AU2001273496A1 (en) * 2000-07-24 2002-02-05 Boehringer Ingelheim Pharmaceuticals Inc. Apparatus and method for predicting the suitability of a substance for dry granulation by roller compaction using small sample sizes
EP1175899B1 (de) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granulat bestehend aus Stärke und Laktose
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
ZA200405008B (en) 2005-08-31
CN1688313A (zh) 2005-10-26
DK1467737T3 (da) 2006-09-18
EP1467737A1 (de) 2004-10-20
AU2003214326B2 (en) 2007-08-02
JP2005529068A (ja) 2005-09-29
NZ533820A (en) 2005-08-26
UA78277C2 (en) 2007-03-15
CN100352440C (zh) 2007-12-05
EA007286B1 (ru) 2006-08-25
ATE327758T1 (de) 2006-06-15
PT1467737E (pt) 2006-08-31
FR2834894A1 (fr) 2003-07-25
PL370168A1 (en) 2005-05-16
EA200400885A1 (ru) 2004-12-30
AR038194A1 (es) 2005-01-05
DE60305642T2 (de) 2007-05-16
EP1467737B1 (de) 2006-05-31
KR100588223B1 (ko) 2006-06-12
HK1081110A1 (en) 2006-05-12
ES2263959T3 (es) 2006-12-16
GEP20063819B (en) 2006-05-10
FR2834894B1 (fr) 2004-02-27
CA2473152A1 (fr) 2003-07-31
WO2003061661A1 (fr) 2003-07-31
JP4500051B2 (ja) 2010-07-14
BR0306869A (pt) 2004-11-03
PL204939B1 (pl) 2010-02-26
US20050085485A1 (en) 2005-04-21
KR20040075098A (ko) 2004-08-26
MXPA04007035A (es) 2004-10-11
NO20043474L (no) 2004-08-20
CY1105414T1 (el) 2010-04-28
CA2473152C (fr) 2010-08-31
MA27098A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
DE60304993D1 (de) In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
DE60307082D1 (de) In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
DE60332393D1 (de) Flüssige pharmazeutische zusammensetzung mit pyridonderivaten
ATE336264T1 (de) Dispergierbare pharmazeutische zusammensetzungen
DE60111769D1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
PT1919894E (pt) Novos derivados de poliquinolinas e a sua utilização terapêutica
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
PL388076A1 (pl) Doustna postać dawki o przedłużonym uwalnianiu oksykodonu i jej zastosowanie
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
DE602004025950D1 (de) Pharmazeutische formulierung mit lanthanum-verbindungen
DE60319848D1 (de) Medikament mit mesenchym-stammzellen
ATE355271T1 (de) Pharmazeutische zusammensetzung
ATE381335T1 (de) 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung
IL182624A0 (en) 2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
ITRM20020042U1 (it) Manico componibile perfezionato, in particolare manico per scope e simili.
ZA200804163B (en) New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions
DE60305728D1 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG
ATE420118T1 (de) Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung
IL181216A (en) 5, 3-SICO-4-NORKOLSTAN DERIVATIVES AND PHARMACEUTICAL COMPONENTS CONTAINING @ THEM
DE60310526D1 (de) Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
DE60330764D1 (de) Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
DE60129238D1 (de) Pharmazeutische zusammensetzung
DE60306747D1 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition